Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (4,809,088)	$ (10,913,615)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	3,300,655	3,280,843
Stock based compensation	2,930,575	2,761,566
Bad debt expense (recovery)	116,000	(90,000)
Amortization of discounts on notes payable and debt issuance costs	445,867	80,332
Revaluation of Warrant Liability	(82,471)
Changes in operating assets and liabilities:
Accounts receivable - trade	2,000,539	2,426,771
Prepaid expenses, other current assets, and other assets	(314,278)	650,190
Accounts payable and accrued expenses	(1,657,410)	958,364
Deferred revenue	(62,650)	491,762
Net cash provided by operating activities	1,867,739	712,978
Cash flows from investing activities:
Purchase of property and equipment	(590,385)	(128,515)
Loan payments received from BRC		111,569
Net cash used in investing activities	(590,385)	(16,946)
Cash flows from financing activities:
Proceeds from exercise of stock options and warrants		122,686
Proceeds from issuance of common stock	10,572,559
Proceeds from the issuance of debt		5,000,000
Payments of capital leases	(702,164)	(566,103)
Payments on long-term debt	(1,851,413)	(1,573,906)
Net cash provided by financing activities	8,018,982	2,982,677
Effect of foreign currency exchange rate on cash	(28,902)	(18,475)
Net increase in cash and cash equivalents	9,267,434	3,660,234
Cash and cash equivalents at beginning of the period	6,330,532	5,022,007
Cash and cash equivalents at end of period	15,597,966	8,682,241
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	422,661	127,486
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Purchase of property and equipment through capital leases	167,354	498,659
Subordinated note payable and accounts receivable offset		6,025,898
Warrant exercises and subordinated notes payable cancellations		2,756,210
Warrant exercise settlement	174,891
Issuance of convertible note payable for settlement loss contingency for trademark dispute		600,000
Issuance of warrants and valuation discount on debt		290,748
Noncash Portion [Member]
Adjustments to reconcile net loss to net cash provided by operating activities:
Loss on debt restructure		$ 1,066,765